The Biomarker TCONS_00016233 Drives Septic AKI by Targeting the miR-22-3p/AIFM1 Signaling Axis
Open Access
- 14 January 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy Nucleic Acids
- Vol. 19, 1027-1042
- https://doi.org/10.1016/j.omtn.2019.12.037
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (81870475, 81570646, 81770951)
- Hunan Province Natural Science Foundation (2018JJ2568)
- Youth Foundation of Hu’nan Scientific Committee (2017JJ1035)
- Changsha Science and Technology Bureau Project (kq1901115)
This publication has 42 references indexed in Scilit:
- Hyperglycemia, p53, and mitochondrial pathway of apoptosis are involved in the susceptibility of diabetic models to ischemic acute kidney injuryKidney International, 2015
- Acute kidney injury—epidemiology, outcomes and economicsNature Reviews Nephrology, 2014
- Characterization of human plasma-derived exosomal RNAs by deep sequencingBMC Genomics, 2013
- Accuracy of plasma neutrophil gelatinase-associated lipocalin in the early diagnosis of contrast-induced acute kidney injury in critical illnessIntensive Care Medicine, 2013
- Discovery and validation of cell cycle arrest biomarkers in human acute kidney injuryCritical Care, 2013
- Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s)Kidney International, 2012
- Apoptosis and acute kidney injuryKidney International, 2011
- Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illnessIntensive Care Medicine, 2009
- Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsJournal of the American Society of Nephrology, 2005
- Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injuryKidney International, 2002